JP2024503723A5 - - Google Patents
Info
- Publication number
- JP2024503723A5 JP2024503723A5 JP2023543239A JP2023543239A JP2024503723A5 JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5 JP 2023543239 A JP2023543239 A JP 2023543239A JP 2023543239 A JP2023543239 A JP 2023543239A JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- adenosine derivative
- derivative according
- composition according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163141450P | 2021-01-25 | 2021-01-25 | |
| US63/141,450 | 2021-01-25 | ||
| PCT/US2022/013660 WO2022159872A1 (en) | 2021-01-25 | 2022-01-25 | Adenosine derivative and pharmaceutical composition comprising the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024503723A JP2024503723A (ja) | 2024-01-26 |
| JP2024503723A5 true JP2024503723A5 (cg-RX-API-DMAC7.html) | 2025-01-15 |
| JP7843289B2 JP7843289B2 (ja) | 2026-04-09 |
Family
ID=82494279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543239A Active JP7843289B2 (ja) | 2021-01-25 | 2022-01-25 | アデノシン誘導体及びそれを含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11793827B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4281081A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7843289B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230132476A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116710465A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022210781A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3202049A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304366A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008004A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022159872A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202408803B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL289925B2 (en) | 2019-07-27 | 2026-03-01 | Brii Biosciences Inc | A derivative of adenosine and a pharmaceutical preparation containing it |
| AU2022211056A1 (en) | 2021-01-25 | 2023-07-20 | Brii Biosciences, Inc. | Combination therapy for hiv with adenosine derivative and capsid inhibitors |
| KR20230132476A (ko) | 2021-01-25 | 2023-09-15 | 브리 바이오사이언시스, 인크. | 아데노신 유도체 및 이를 포함하는 약제학적 조성물 |
| EP4658663A2 (en) * | 2023-01-30 | 2025-12-10 | Merck Sharp & Dohme LLC | Prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3407191A (en) * | 1966-08-29 | 1968-10-22 | Lilly Co Eli | Adamantoate esters of nucleosides |
| US5880154A (en) | 1994-02-01 | 1999-03-09 | The Board Of Regents Of The University Of Nebraska | Polymeric adamantane analogues |
| EP1667694B1 (en) | 2003-09-05 | 2010-04-28 | Anadys Pharmaceuticals, Inc. | Tlr7 ligands for the treatment of hepatitis c |
| CA2502109C (en) | 2004-03-24 | 2010-02-23 | Yamasa Corporation | 4'-c-substituted-2-haloadenosine derivative |
| EP1915053A2 (en) | 2005-08-12 | 2008-04-30 | Merck & Co., Inc. | Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives |
| EP2040712B1 (en) | 2006-07-18 | 2011-03-02 | Anadys Pharmaceuticals, Inc. | Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| WO2011058582A1 (en) | 2009-11-16 | 2011-05-19 | Orchid Research Laboratories Ltd. | Histone deacetylase inhibitors for the treatment of fungal infections |
| WO2015143712A1 (en) * | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
| WO2015187596A2 (en) | 2014-06-02 | 2015-12-10 | Regeneron Pharmaceuticals, Inc. | Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses |
| JP6768796B2 (ja) * | 2015-09-23 | 2020-10-14 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 4’−置換ヌクレオシド逆転写酵素阻害剤及びその調製 |
| US20180030080A1 (en) * | 2016-07-28 | 2018-02-01 | Alexandre Vasilievich Ivachtchenko | Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their use |
| US10266558B2 (en) * | 2016-10-07 | 2019-04-23 | Alexandre Vasilievich Ivachtchenko | Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof |
| US11337964B2 (en) | 2017-02-28 | 2022-05-24 | Kangpu Biopharmaceuticals, Ltd. | Isoindoline derivative, pharmaceutical composition and use thereof |
| RU2659388C1 (ru) * | 2017-02-28 | 2018-07-02 | Васильевич Иващенко Александр | Нуклеотиды, включающие N-[(S)-1-циклобутоксикарбонил]фосфорамидатный фрагмент, их аналоги и их применение |
| US20190185508A1 (en) * | 2017-12-15 | 2019-06-20 | Merck Sharp & Dohme Corp. | Deuterated nucleoside reverse transcriptase inhibitors |
| WO2019171285A1 (en) * | 2018-03-07 | 2019-09-12 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds useful in hiv therapy |
| CN109053803A (zh) | 2018-07-04 | 2018-12-21 | 米文君 | 一类新的化合物及其用途 |
| MA53280A (fr) * | 2018-08-09 | 2021-11-17 | Glaxosmithkline Ip No 2 Ltd | Composés utiles dans la thérapie du vih |
| US20210323993A1 (en) * | 2018-08-30 | 2021-10-21 | Glaxosmithkline Intellectual Property (No. 2) Limited | Compounds Useful in HIV Therapy |
| PH12021500034A1 (en) * | 2019-03-06 | 2022-06-06 | Glaxosmithkline Ip No 2 Ltd | Compounds useful in hiv therapy |
| IL289925B2 (en) | 2019-07-27 | 2026-03-01 | Brii Biosciences Inc | A derivative of adenosine and a pharmaceutical preparation containing it |
| WO2021038509A1 (en) | 2019-08-28 | 2021-03-04 | Glaxosmithkline Intellectual Property (No.2) Limited | 4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy |
| MX2022002897A (es) | 2019-09-11 | 2022-05-16 | Scripps Research Inst | Profarmacos antivirales y formulaciones de los mismos. |
| AU2022211056A1 (en) | 2021-01-25 | 2023-07-20 | Brii Biosciences, Inc. | Combination therapy for hiv with adenosine derivative and capsid inhibitors |
| KR20230132476A (ko) * | 2021-01-25 | 2023-09-15 | 브리 바이오사이언시스, 인크. | 아데노신 유도체 및 이를 포함하는 약제학적 조성물 |
-
2022
- 2022-01-25 KR KR1020237024605A patent/KR20230132476A/ko active Pending
- 2022-01-25 JP JP2023543239A patent/JP7843289B2/ja active Active
- 2022-01-25 EP EP22743369.5A patent/EP4281081A4/en active Pending
- 2022-01-25 US US17/583,805 patent/US11793827B2/en active Active
- 2022-01-25 AU AU2022210781A patent/AU2022210781A1/en active Pending
- 2022-01-25 CN CN202280009277.3A patent/CN116710465A/zh active Pending
- 2022-01-25 CA CA3202049A patent/CA3202049A1/en active Pending
- 2022-01-25 MX MX2023008004A patent/MX2023008004A/es unknown
- 2022-01-25 WO PCT/US2022/013660 patent/WO2022159872A1/en not_active Ceased
-
2023
- 2023-07-10 IL IL304366A patent/IL304366A/en unknown
- 2023-09-15 US US18/467,985 patent/US12390484B2/en active Active
-
2024
- 2024-11-20 ZA ZA2024/08803A patent/ZA202408803B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541667A5 (cg-RX-API-DMAC7.html) | ||
| JP7719769B2 (ja) | 抗ウイルスプロドラッグ及びその医薬組成物 | |
| JP5027885B2 (ja) | 水難溶性カンプトテシン誘導体のサブミクロンナノ粒子及びその製造方法 | |
| JP6445591B2 (ja) | シロリムス及びその誘導体の複合体、それらの調製方法ならびにそれらを含有する医薬組成物 | |
| JP2002510329A (ja) | 親油性化合物用の自己乳化性処方 | |
| JP2007500229A5 (cg-RX-API-DMAC7.html) | ||
| PT96289B (pt) | Processamento para a preparacao de composicoes farmaceuticas para o trtamento de infeccoes virais | |
| JP2021521222A (ja) | 6,8−ビス−ベンジルチオ−オクタン酸を使用して前立腺癌を治療するための治療方法および組成物 | |
| JP2006070032A (ja) | 抗血管形成薬剤組成物 | |
| US20220054445A1 (en) | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor | |
| RU2358730C2 (ru) | Производное эпотилона для лечения гепатомы и других раковых заболеваний | |
| EP4157290A1 (en) | Compositions, their uses in therapy and methods thereof | |
| JP2022521119A5 (cg-RX-API-DMAC7.html) | ||
| JP2009504746A (ja) | 第Xa因子インヒビターのシクロデキストリン包接複合体 | |
| CN104080449A (zh) | 4,9-二羟基-萘并[2,3-b]呋喃脂肪酸酯衍生物的纳米颗粒水悬液的制备方法 | |
| CA3121929A1 (en) | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor | |
| JP4090133B2 (ja) | 抗マラリア剤 | |
| RU2488398C2 (ru) | Фармацевтическая комбинация опиоида и простагландинового соединения | |
| CN105163732A (zh) | 用于治疗眼科疾病和病症的方法 | |
| JPH10503178A (ja) | Hiv感染のための組合わせ療法 | |
| WO2014015153A2 (en) | Compositions and methods for treating ewing's sarcoma and other disorders related to ews-fli1 | |
| JP2013529686A5 (cg-RX-API-DMAC7.html) | ||
| RU2022104985A (ru) | Аденозиновое производное и фармацевтическая композиция, содержащая его | |
| EP0310259A2 (en) | Eperisone as a hypotensive agent | |
| US20170165231A1 (en) | Treating ewing's sarcoma and ews-fli1 related disorders |